ProF-001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ProF-001, covering 2019-03-14 to 2022-09-22. Get the full timeline:
Most recent: Clinical Trial Update: A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) [Phase 2, Phase 3]